2019 - What to Expect from FDA's Approach to Regulate Medical Software
Date2019-07-09
Deadline2019-07-09
VenueOnline Event, USA - United States
KeywordsMedical Software; Medical device oversight; FDA’s Software Recertification
Topics/Call fo Papers
FDA’s history in regulating medical software
Evolution of FDA’s regulatory framework
21st Century Cures Act clarifies FDA jurisdiction
Software functions excluded from medical device oversight
Medical software as a medical device (SaMD) and software in a medical device (SiMD)
Overview of FDA’s Digital Health Innovation Action Plan
FDA’s Software Recertification Program and 2019 Test Plan
Summary of FDA’s new regulatory framework
Role of stakeholders in FDA’s revised
What are the FDA’s next steps
Key questions about FDA’s streamlined regulatory approach
Implications for health software industry
Evolution of FDA’s regulatory framework
21st Century Cures Act clarifies FDA jurisdiction
Software functions excluded from medical device oversight
Medical software as a medical device (SaMD) and software in a medical device (SiMD)
Overview of FDA’s Digital Health Innovation Action Plan
FDA’s Software Recertification Program and 2019 Test Plan
Summary of FDA’s new regulatory framework
Role of stakeholders in FDA’s revised
What are the FDA’s next steps
Key questions about FDA’s streamlined regulatory approach
Implications for health software industry
Other CFPs
- 20th IEEE/ACM International Symposium on Cluster, Cloud and Internet Computing (CCGrid 2020)
- 4th IEEE International Workshop on Vehicular Information Services for the Internet of Things (VISIT '19)
- Recovery and Resolution Planning, London
- 3rd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
- Anti-Money Laundering, London
Last modified: 2019-06-24 00:14:31